On my way to airport and 17h trip to Helsinki. But it was worth it; thanks #AACR24 for excellent organization and @cncurtis and others for awesome scientific program! Below some poster action pics @matiasmfalco, @ntn_mai, @alexalah and @Vesselinka. 💪
When you plan your schedule for Tuesday in #AACR24, consider visiting @ntn_mai poster on #ctdna release mechanisms! Mai’s poster is ’Unraveling ctDNA features in high serous ovarian carcinoma and insights from genomic and transcriptomic integration’ is in Section 37 at 9.00-12.30
#AACR24 visit poster at session 37, board 5 for the integration of multi omics in #ctdna release mechanisms and #fragmentomics in longitudinal monitoring
Interested in @deciderproject latest results on #tumorevolution and participating #AACR24? Visit my poster ’Tumor evolution during therapy in ovarian cancer’ in the Tumor Evolution in Space and Time session on Monday 9-12 (Section 12)!
#AACR24 visit poster at session 37, board 5 for the integration of multi omics in #ctdna release mechanisms and #fragmentomics in longitudinal monitoring
Now online in @CD_AACR: BRCA1-mediated Dual Regulation of #Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-inhibition in BRCA1-deficient Cancers - by Guang Lei @BoyiGan and colleagues https://t.co/gXbchx4Ry7 @MDAndersonNews
Multi-Omics Analysis Reveals the Attenuation of the Interferon Pathway as a Driver of Chemo-Refractory Ovarian Cancer https://t.co/LWQD9GURjb #biorxiv_cancer
A comprehensive 5★ perspective/review on cancer as a complex, systemic disease with all the hallmarks https://t.co/tV5VPHBmHA @CellCellPress by @CharlesSwanton and colleagues
How to identify personalised combination immunotherapies for #ovariancancer patients? We generated iPDCs- a functional immuno-oncology platform! Check out our new preprint from @SystemTumor https://t.co/9s34aBjPon